NCT05030415View on ClinicalTrials.gov

Ixekizumab in Adult Patients With Lichen Planus and Lichen Planopilaris

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

August 12, 2021

Primary Completion Date

March 25, 2024

Study Completion Date

March 25, 2024

Conditions
Lichen Planus ScalpLichen PlanusLichen Planopilaris
Interventions
DRUG

Ixekizumab Auto-Injector

160 mg week 0 followed by 80 mg every two weeks

Trial Locations (1)

87102

University of New Mexico, Albuquerque

All Listed Sponsors
lead

University of New Mexico

OTHER

NCT05030415 - Ixekizumab in Adult Patients With Lichen Planus and Lichen Planopilaris | Biotech Hunter | Biotech Hunter